Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,317 | -18,663 | -66,052 | -51,707 | -34,167 |
| Depreciation Amortization | 22 | 11 | 205 | 153 | 102 |
| Accounts payable and accrued liabilities | 128 | 678 | 1,295 | 285 | 1,964 |
| Other Working Capital | 3,605 | 6,461 | -1,684 | -3,900 | 1,675 |
| Other Operating Activity | 4,546 | 2,611 | 9,562 | 8,745 | 5,103 |
| Operating Cash Flow | $-17,016 | $-8,901 | $-56,675 | $-46,424 | $-25,325 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,000 | 30,000 | 10,000 | 10,000 | 10,000 |
| Debt Repayment | -10,226 | -10,223 | -12,319 | -12,313 | -717 |
| Common Stock Issued | 24,298 | 24,637 | 62,513 | 60,881 | 60,588 |
| Other Financing Activity | -824 | -569 | -600 | -600 | -600 |
| Financing Cash Flow | $43,248 | $43,845 | $59,594 | $57,968 | $69,271 |
| Beginning Cash Position | 17,397 | 17,397 | 14,477 | 14,477 | 14,477 |
| End Cash Position | 43,629 | 52,341 | 17,397 | 26,021 | 58,424 |
| Net Cash Flow | $26,232 | $34,944 | $2,920 | $11,544 | $43,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,016 | -8,901 | -56,675 | -46,424 | -25,325 |
| Free Cash Flow | -17,016 | -8,901 | -56,675 | -46,424 | -25,325 |